Feinberg Peter — SEC Form 4 filings
SEC reporting owner CIK 1870076. 14 Form 4 filings on record with FilingPulse; latest filed 2026-06-11.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-01-26 to 2026-06-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 9 legs across 7 filings — 165,000 shares, $535,517 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: purchase of 45,024 shares @ $2.31 ($103,857) in Immuneering Corp, filed 2024-03-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Immuneering Corp (IMRX) | Director | 12 | 9 legs · 165,000 sh · $535,517 | — | 5 |
| Notable Labs, Ltd. (NTBL) | Director | 2 | — | — | 2 |
Form 4 filings — Feinberg Peter
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-11 | 4 | Immuneering Corp (IMRX) | Grant/award (A): 33,350 (derivative) @ $0 | EDGAR |
| 2026-01-14 | 4 | Immuneering Corp (IMRX) | Purchase (P): 20,000 @ $4.35 | EDGAR |
| 2026-01-02 | 4 | Immuneering Corp (IMRX) | Grant/award (A): 7,888 (derivative) @ $0 | EDGAR |
| 2025-10-07 | 4 | Immuneering Corp (IMRX) | Purchase (P): 7,500 @ $6.67 | EDGAR |
| 2025-10-01 | 4 | Immuneering Corp (IMRX) | Purchase (P): 7,500 @ $7.03 | EDGAR |
| 2025-09-30 | 4 | Immuneering Corp (IMRX) | Purchase (P): 5,000 @ $7.18 | EDGAR |
| 2025-06-23 | 4 | Immuneering Corp (IMRX) | Purchase (P): 25,000 @ $2.53 | EDGAR |
| 2025-06-16 | 4 | Immuneering Corp (IMRX) | Grant/award (A): 33,350 (derivative) @ $0 | EDGAR |
| 2025-01-02 | 4 | Immuneering Corp (IMRX) | Grant/award (A): 23,485 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Immuneering Corp (IMRX) | Grant/award (A): 33,350 (derivative) @ $0 | EDGAR |
| 2024-05-10 | 4 | Notable Labs, Ltd. (NTBL) | Grant/award (A): 40,247 @ $0 | EDGAR |
| 2024-03-25 | 4 | Immuneering Corp (IMRX) | Purchase (P): 25,000 @ $2.55 | EDGAR |
| 2024-03-19 | 4 | Immuneering Corp (IMRX) | Purchase (P): 45,024 @ $2.31 · Purchase (P): 4,976 @ $3.05 · Purchase (P): 25,000 @ $2.56 | EDGAR |
| 2024-01-26 | 4 | Notable Labs, Ltd. (NTBL) | Grant/award (A): 9,753 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1870076 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →